Establishment of potent TCR-T cells specific for cisplatin-resistance related tumor-associated antigen, CLSPN using codon-optimization

Establishment of potent TCR-T cells specific for cisplatin-resistance related tumor-associated antigen, CLSPN using codon-optimization

<p>Adoptive T cell therapy, using T cell receptor-engineered T (TCR-T) cells and chimeric antigen receptor T (CAR-T) cells, is a potent immunotherapy option. Bladder cancer is a prevalent urological malignancy, particularly in cases of muscle invasion and metastasis, for which systemic therapy...

Full description

Saved in:
Bibliographic Details
Main Author: Kanta Hori (20198286) (author)
Other Authors: Shuhei Yamada (2501758) (author), Kenji Murata (500161) (author), Haruka Miyata (3947141) (author), Yuka Mizue (363693) (author), Aiko Murai (683051) (author), Tomoyuki Minowa (20198289) (author), Kenta Sasaki (5945867) (author), Naoki Shijubou (14831091) (author), Terufumi Kubo (482426) (author), Rena Morita (418953) (author), Serina Tokita (11869652) (author), Takayuki Kanaseki (482424) (author), Tomohide Tsukahara (482423) (author), Takashige Abe (7302572) (author), Nobuo Shinohara (667646) (author), Yoshihiko Hirohashi (93294) (author), Toshihiko Torigoe (93291) (author)
Published: 2024
Subjects:
Cell Biology
Immunology
Cancer
Hematology
Infectious Diseases
Space Science
Urothelial carcinoma
CLSPN
cisplatin resistance
TCR-T
immunotherapy
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items